Ⅰ<sub>B</sub>—Ⅱ<sub>A</sub>期年轻宫颈癌临床特点及预后分析

doi:10.3760/cma.j.issn.1004-4221.2015.03.008

摘要
图/表
参考文献()
相关文章 (15)
点击分布统计
下载分布统计

全文: PDF (0 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS) 背景资料

摘要目的探讨年龄≤35岁Ⅰ_B—Ⅱ_A期宫颈癌患者的临床病理特点、生存情况及术后放疗对卵巢功能影响。方法对2000—2011年本院收治的 186例患者进行回顾分析,并根据期别进行配平选取同期年龄>35岁宫颈癌患者 186例作为对照。Kaplan-Meier法计算生存率Logrank法检验和单因素预后分析,Cox模型多因素预后分析。结果年龄≤35岁组中非鳞状细胞癌所占比例高于对照组(P=0.000),而肿瘤侵犯>1/2宫颈间质、淋巴血管间隙受侵发生率低于对照组(P=0.008、0.000)。尽管年轻患者 5年DFS和OS率均高于对照组(93.7%∶84.5%,P=0.005和96.1%∶89.5%,P=0.033),但年龄本身并非预后影响因素(P=0.202、0.950)。在年龄≤35岁患者中淋巴结转移及淋巴血管间隙受侵为DFS的影响因素(P=0.000、0.000),淋巴血管间隙受侵及治疗前肿瘤大小则是OS的影响因素(P=0.000、0.000)。接受卵巢移位术后外放疗的年轻患者63%卵巢功能正常,未接受的为73%(P=0.422)。结论 Ⅰ_{B—Ⅱ_A期宫颈癌中年龄≤35岁者预后优于对照组,但年龄本身并非预后影响因素。术后外放疗不会对移位后的卵巢功能造成影响。}

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	张功逸
	张蓉
	曾靖
	雷呈志
	吴令英

关键词 ：宫颈肿瘤/放射疗法, 年龄, 预后, 卵巢功能

Abstract：Objective To investigate the clinicopathological features, survival, and the impact of postoperative adjuvant radiotherapy on the ovarian function in patients less than or equal to 35 years of age with stage I_B-II_A cervical cancer. Methods One hundred and eighty-six patients who were admitted to our hospital from 2000 to 2011 were retrospectively analyzed. An equal number of patients older than 35 years of age with cervical cancer within the same period were used as stage-marched controls. The Kaplan-Meier method was used to calculate the survival rates, and the log-rank test was used for pairwise comparison and univariate prognostic analyses. The Cox proportional hazards model was used for multivariate prognostic analyses. Results The patients less than or equal to 35 years of age had a significantly higher incidence of non-squamous carcinoma but significantly lower incidence rates of deep stromal invasion and lymph-vascular space invasion (LVSI) compared with the control group (P=0.000;P=0.008;P=0.000). Though young patients had significantly higher 5-year disease-free survival (DFS) and overall survival (OS) rates than the control group (93.7% vs. 84.5%, P=0.005;96.1% vs. 89.5%, P=0.033), age was not an independent prognostic factor (P=0.202;P=0.950). Among patients less than or equal to 35 years of age, lymph node metastasis and LVSI were independent prognostic factors for DFS (P=0.000;P=0.000), while LVSI and initial tumor size were independent prognostic factors for OS (P=0.000;P=0.000). There was no significant difference in the incidence of normal ovarian function between young patients treated withand without adjuvant radiotherapy after ovarian transposition (63% vs. 73%, P=0.422). Conclusions
Patients less than or equal to 35 years of age with stage I_B-II_A cervical cancer have a better prognosis than the control group. However, age is not an independent prognostic factor. Postoperative adjuvant radiotherapy will not impair the function of transposed ovaries.

Key words： Cervical neoplasms/radiotherapy Age Prognosis Ovarian function

通讯作者: 张蓉,Emailsuper0078888@sina.com

引用本文:

张功逸,张蓉,曾靖等. Ⅰ_B—Ⅱ_A期年轻宫颈癌临床特点及预后分析[J]. 中华放射肿瘤学杂志, 2015, 24(3): 262-266.

Zhang Gongyi,Zhang Rong,Zeng Jing et al. Clinical characteristics and prognostic analysis of young patients with stage I_B-II_A cervical cancer[J]. Chinese Journal of Radiation Oncology, 2015, 24(3): 262-266.

链接本文:

http://journal12.magtechjournal.com/Jweb_fszlx/CN/10.3760/cma.j.issn.1004-4221.2015.03.008 或 http://journal12.magtechjournal.com/Jweb_fszlx/CN/Y2015/V24/I3/262

[1] Foley G, Alston R, Geraci M, et al. Increasing rates of cervical cancer in young women in England:an analysis of national data 1982-2006[J]. Br J Cancer,2011,105(1):177-184.DOI:10.1038/bjc.2011.196.
[2] 章文华,白萍,吴令英,等.35岁以下妇女宫颈癌[J].中国肿瘤临床与康复,1999,6(6):39-43.
[3] 马珂,刘桐宇,黄伟萍,等.手术及术后化疗治疗有复发中危和高危因素的Ⅰ_{B-Ⅱ_A期宫颈癌68例疗效分析[J].实用妇产科杂志,2012,28(11):923-927.DOI:10.3969/j.issn.1003-6946.2012.11.011.
[4] 张乃怿,高雨农,燕鑫,等.具复发危险因素的Ⅰ_{B1-Ⅱ_A期宫颈癌术后辅助化疗的疗效和安全性评价[J].实用妇产科杂志,2014,30(1):21-25.
[5] 刘兰芳,孙海燕.831例35岁以下妇女宫颈癌的临床病例特点和预后[J].中国癌症杂志,2008,18(4):298-301.DOI:10.3969/j.issn.1007-3639.2008.04.014.
[6] Brewster WR, Disaia PJ, Monk BJ, et al. Young age as a prognostic factor in cervical cancer:Results of a population-based study[J]. Am J Obstet Gynecol,1999,180(6 Pt 1):1464-1467.
[7] Lou HY, Juang CM, Chen YJ, et al. Aggressive characteristics of cervical cancer in young women in Taiwan[J].Int J Gynaecol Obstet,2009,107(3):220-223.DOI:10.1016/j.ijgo.2009.07.029.
[8] Castanon A, Leung VMW, Landy R, et al. Charatoristics and screening history of women diagnosed with cervical cancer aged 20-29 years[J]. Br J Cancer,2013,109(1):35-41.DOI:10.1038/bjc.2013.322.
[9] Lavazzo C, Darlas FM, Gkegkes LD, et al. The role of robotics in ovarian transposition[J]. Acta Inform Med,2013,21(2):135-137.DOI:10.5455/aim.2013.21.135-137.
[10] Zhao YB, Wang JH, Chen XX, et al. Values of three different preoperative regimens in comprehensive treatment for young patients with stage Ⅰ_{b2 cervical cancer[J]. Asian Pacific J Cancer Prev,2012,13(4):1487-1489.
[11] Gubbala K, Laios A, Gallos L, et al. Outcomes of ovarian transposition in gynaecological cancers:a systematic review and meta-analysis[J]. J Ovarian Res,2014,7(1):69-79.DOI:10.1186/1757-2215-7-69.
[12] Kastritis E, Bamias A, Bozas G, et al. The impact of age in the outcome of patients with advanced or recurrent cervical cancer after platinum-based chemotherapy[J]. Gynecol Oncol,2007,104(2):372-376.}}}